Skip to main content

Colorectal Cancer (CRC)

Despite expanded CRC screening guidelines and increased awareness, CRC remains a leading cause of cancer related death, including among adults under age 50.¹⁻²
Mother with cancer and middle aged son sitting down and laughing

Spanning the continuum of care with a comprehensive colorectal testing portfolio

Our routine and specialty labs offer comprehensive menu of key tests to help screen, diagnose, monitor and manage colorectal cancer.

For individuals & patients

Learn what colorectal cancer is and whether you are at average risk.

Patient Screening Information
Middle aged woman in a swing

For primary care providers

Understand barriers to screening and when stool-based testing might be appropriate to introduce. 

Screening Barriers & Options
Provider meeting with a patient to go over results

For Oncologists & pathologists

Explore our complete portfolio of colorectal testing from early screening to treatment and follow-up. 

Colorectal Test Portfolio
Middle aged man staring off into the distance outside

Flexible CRC screening options designed for primary care workflows:

ColoSense® offered by Labcorp

The first FDA-approved, multi-target stool-RNA (mt-sRNA) screening test that improves detection of CRC and advanced adenomas

  • Recommended every three years for adults age 45+ at average risk for CRC
  • Identifies biomarkers linked to CRC
  • Simplified at-home collection to support patient adherence 
ColoSense for Patients

ColoFIT® Home Collection Test

A simple at-home fecal immunochemical test (FIT)

  • Recommended annually for adults age 45+ at average risk for CRC
  • Detects hemoglobin in stool
  • Convenient option with in-office pickup/Labcorp patient service center return
ColoFIT for Patients

Latest resources for colorectal cancer

References

  1. Count on you, 2025 edition
  2. Siegel RL, Wagle NS, Jemal A. Leading cancer deaths in people younger than 50 years. JAMA. Published online January 22, 2026. doi:10.1001/jama.2025.25467